A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours	Solid Tumours	Recruiting	Phase 1 / Phase 2	2026-05-08		NCT06725758

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Orion Corporation, Orion Pharma	5

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Oscar Lambret	Lille	France	61
Helsinki University Hospital	Helsinki	Finland	46
Hospital 12 de Octubre	Madrid	Spain	13
Hospital Virgen de la Macarena	Seville	Spain	4
Institut Bergonie	Bordeaux	France	26
Institut Gustave Roussy	Villejuif	France	58
Istituto Oncologico, Ospedale Bellinzona e Valli	Bellinzona	Switzerland	1
Jefferson University Hospital	Philadelphia	United States	3
Leicester Royal Infirmary	Leicester	United Kingdom	19
Memorial Sloan Kettering Cancer Center	New York	United States	1000
NEXT Virginia	Fairfax	United States	83
Oulu University Hospital	Oulu	Finland	44
Royal Marsden Hospital, London, UK	London	United Kingdom	1
Siteman Cancer Center	St Louis	United States	10
Turku University Hospital	Turku	Finland	61
UC Irvine Health	Orange	United States	20
University of Texas, MD Anderson Cancer Center	Houston	United States	12
Valkyrie Clinical Trials	Los Angeles	United States	47
Westchester Medical Center	Valhalla	United States	53
Weston Park Hospital	Sheffield	United Kingdom	12

Clinical trials